Metastatic Breast Cancer Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
E
Completed
  • Advanced Cancer
  • +5 more
  • Los Angeles, California
  • +7 more
2022-04-07
Apr 7, 2022
W
Recruiting
  • Metastatic Breast Cancer
  • Leptomeningeal Disease
  • High-dose Methotrexate (8 gm/m2; HD-MTX)
  • Baltimore, Maryland
  • +2 more
2022-04-06
Apr 6, 2022
T
Recruiting
  • Advanced Breast Cancer
  • Metastatic Breast Cancer
  • Tianjin, Tianjin, China
    Breast Oncology, Tianjin Medical University Cancer Institute and
2022-04-06
Apr 6, 2022
E
Recruiting
  • Breast Cancer
  • +3 more
  • Gilbert, Arizona
  • +77 more
2022-04-06
Apr 6, 2022
N
Recruiting
  • Advanced Breast Cancer
  • +7 more
  • Anaheim, California
  • +4 more
2022-04-06
Apr 6, 2022
U
Not yet recruiting
  • Metastatic Breast Cancer
  • DOULA-AC 1
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
2022-03-28
Mar 28, 2022
A
Recruiting
  • Metastatic Breast Cancer
  • Trastuzumab deruxtecan
  • +6 more
  • Iowa City, Iowa
  • +57 more
2022-04-05
Apr 5, 2022
U
Recruiting
  • Breast Cancer
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin School of Medicine and Public Health
2022-04-04
Apr 4, 2022
N
Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
2022-04-04
Apr 4, 2022
E
Available
  • Metastatic Breast Cancer
  • Liverpool, New South Wales, Australia
  • +229 more
2022-04-05
Apr 5, 2022
S
Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Denosumab (reduced dosing)
  • Denosumab (standard dosing)
  • Feldkirch, Austria
  • +49 more
2022-04-04
Apr 4, 2022
V
Not yet recruiting
  • Metastatic Breast Cancer
  • Enobosarm & Abemaciclib Combo
  • non-steroidal AI, or steroidal AI (exemestane with or without everolimus) or Fulvestrant
  • Chandler, Arizona
  • +15 more
2022-04-01
Apr 1, 2022
V
Recruiting
  • Metastatic Breast Cancer
  • Anchorage, Alaska
  • +50 more
2022-04-01
Apr 1, 2022
V
Not yet recruiting
  • Metastatic Breast Cancer
  • Sabizabulin
  • Exemestane monotherapy, exemestane plus everolimus, or selective estrogen receptor modulator
  • Anchorage, Alaska
  • +25 more
2022-04-01
Apr 1, 2022
S
Recruiting
  • Metastatic Breast Cancer
  • Ribociclib + Letrozole OR Fulvestrant
  • +2 more
  • Creixomil, Portugal
  • +44 more
2022-04-01
Apr 1, 2022
U
Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
2022-03-31
Mar 31, 2022
C
Not yet recruiting
  • Breast Neoplasms
  • +3 more
  • surgical treatment 1
  • +2 more
  • (no location specified)
2022-03-20
Mar 20, 2022
M
Completed
  • Metastatic Breast Cancer
  • Nurse AMIE (Addressing Metastatic Individuals Every day)
  • Hershey, Pennsylvania
    Hershey Medical Center
2022-03-31
Mar 31, 2022
O
Active, not recruiting
  • Metastatic Breast Cancer
  • Recurrent Breast Cancer
  • Boston, Massachusetts
  • +2 more
2022-03-21
Mar 21, 2022
A
Recruiting
  • Metastatic Breast Cancer
  • None (Observational study)
  • Macquarie, New South Wales, Australia
  • +42 more
2022-03-17
Mar 17, 2022
A
Recruiting
  • Invasive Breast Cancer
  • +3 more
  • Atlanta, Georgia
  • +5 more
2022-03-30
Mar 30, 2022
C
Not yet recruiting
  • Breast Cancer
  • Metastatic Breast Cancer
  • Blood sampling
  • Caen, France
    Centre François Baclesse
2022-03-21
Mar 21, 2022
U
Recruiting
  • Breast Cancer
  • +2 more
    • Monza, Italy
    • +2 more
    2022-03-29
    Mar 29, 2022